Inicio › Enfermedades autoinmunes › California

Ensayos clínicos de Enfermedades autoinmunes en California

28 estudios sobre Enfermedades autoinmunes buscan participantes en California.

Ciudades en California

Texto oficial del estudio (inglés)

Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis

Site Number - 1028, Irvine
Site Number - 1023, Los Angeles
Site Number - 1029, Rancho Mirage
y 1 más

ReclutandoFase 3

Edades de 18 a 80 · Todos los sexos · Actualizado el 13 nov 2026 · NCT07039916

RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy

University of California Irvine - Accepting Adult Patients, Orange
University of California, San Francisco Benioff Children's Hospital - Accepting Young Adult and Juvenile Patients, San Francisco

ReclutandoFase 2/3

Edades de 6 a 75 · Todos los sexos · Actualizado el 13 nov 2026 · NCT06154252

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

University of California Davis Comprehensive Cancer Center, Sacramento

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 12 nov 2026 · NCT03816345

A Study of Mavorixafor in Participants With Congenital and Acquired Primary Autoimmune and Idiopathic Chronic Neutropenic Disorders Who Are Experiencing Recurrent and/or Serious Infections

UC Irvine, Irvine
Orso Health, La Jolla
University of California, Los Angeles-UCLA, Los Angeles

ReclutandoFase 3

Edades de 12 en adelante · Todos los sexos · Actualizado el 12 nov 2026 · NCT06056297

Two Arm, Double-blind, Phase III Study Assessing Efficacy and Safety of Ianalumab Versus Placebo, in Participants With Sjögren's Disease With High Symptom Burden

Medvin Clinical Research, Van Nuys

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 9 nov 2026 · NCT07621809

Study of PTC844 in Participants With Active Rheumatoid Arthritis

Millennium Clinical Trials, Westlake Village

ReclutandoFase 2

Edades de 18 a 70 · Todos los sexos · Actualizado el 6 nov 2026 · NCT07779616

A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia

USC Norris Comprehensive Cancer Center - Keck Medicine of USC, Los Angeles
University of California San Diego Center for Bleeding and Clotting Disorders, San Diego

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 4 nov 2026 · NCT06722235

A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease

Loma Linda University Medical Center, Loma Linda

ReclutandoFase 1

Edades de 18 a 74 · Todos los sexos · Actualizado el 2 nov 2026 · NCT07085104

A Study of JADE101 in Participants With Immunoglobulin A Nephropathy

Jade Clinical Site, Chula Vista

ReclutandoFase 2

Edades de 18 a 60 · Todos los sexos · Actualizado el 30 oct 2026 · NCT07541287

A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia

USC Norris Comprehensive Cancer Center - Keck Medicine of USC, Los Angeles
University of California San Diego Center for Bleeding and Clotting Disorders, San Diego

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 30 oct 2026 · NCT06948318

Study of Anitocabtagene Autoleucel in Participants With Non-Oncology Plasma Cell-Related Diseases

Ronald Reagan UCLA Medical Center, Los Angeles
UC Irvine Medical Center, Orange
Stanford Blood and Marrow Transplant, Palo Alto

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 22 oct 2026 · NCT06626919

A Study Investigating Intravenous Human Normal Immunoglobulin 10% in Adults With Chronic Immune Thrombocytopenia (ITP)

University of Southern California, Los Angeles

ReclutandoFase 3

Edades de 18 a 70 · Todos los sexos · Actualizado el 22 oct 2026 · NCT07059000

RESET-MG: A Study to Evaluate the Safety and Efficacy of CABA-201 in Participants With Generalized Myasthenia Gravis

University of California Irvine, Orange
UC Davis, Department of Neurology, Sacramento
University of California, San Francisco, San Francisco

ReclutandoFase 1/2

Edades de 18 a 70 · Todos los sexos · Actualizado el 19 oct 2026 · NCT06359041

A Phase 1/2, Open-label, Safety and Dosing Study of Autologous CART Cells (Desmoglein 3 Chimeric Autoantibody Receptor T Cells [DSG3-CAART] or CD19-specific Chimeric Antigen Receptor T Cells [CABA-201]) in Subjects With Active, Pemphigus Vulgaris (RESET-PV)

Stanford University, Dept. of Dermatology, Redwood City
UC Davis, Dept. of Dermatology, Sacramento

ReclutandoFase 1/2

Edades de 18 en adelante · Todos los sexos · Actualizado el 15 oct 2026 · NCT04422912

RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus

University of California Irvine, Orange
UC Davis Health, Sacramento

ReclutandoFase 1/2

Edades de 12 a 65 · Todos los sexos · Actualizado el 6 oct 2026 · NCT06121297

Remdesivir for the Treatment of Upper Respiratory Tract Infection Due to RSV in Immunocompromised Individuals

City of Hope Comprehensive Cancer Center, Duarte

ReclutandoFase 2

Edades de 18 en adelante · Todos los sexos · Actualizado el 1 oct 2026 · NCT06817889

A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease

GSK Investigational Site, Los Angeles
GSK Investigational Site, Los Angeles
GSK Investigational Site, Orange
y 2 más

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 8 sept 2026 · NCT06572384

Study of BHV-1300 in Graves' Disease

Site-103, South Gate

ReclutandoFase 1

Edades de 18 a 65 · Todos los sexos · Actualizado el 31 jul 2026 · NCT06980649

KYSA-6: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy, in Patients With Generalized Myasthenia Gravis

Ronald Reagan UCLA Medical Center, Los Angeles
University of California, Irvine, Orange
Stanford University Medical Center, Palo Alto

ReclutandoFase 2/3

Edades de 18 a 75 · Todos los sexos · Actualizado el 29 jul 2026 · NCT06193889

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

City of Hope, Duarte
Children's Hospital of Los Angeles, Glendale
Scripps Green Hospital, La Jolla
y 8 más

ReclutandoEstudio observacional

Todas las edades · Todos los sexos · Actualizado el 6 jul 2026 · NCT01351545

Study of Single Doses of SBT777101 in Subjects With Rheumatoid Arthritis

UCSF Medical Center, San Francisco
Stanford Medical Center, Stanford

ReclutandoFase 1

Edades de 18 a 70 · Todos los sexos · Actualizado el 30 jun 2026 · NCT06201416

Atacicept in Multiple Glomerular Diseases

Vera Therapeutics, Brisbane

ReclutandoFase 2

Edades de 2 en adelante · Todos los sexos · Actualizado el 26 jun 2026 · NCT06983028

A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease

Wallace Rheumatic Center, Beverly Hills
Providence Medical Foundation, Fullerton
University of California Irvine, Irvine
y 2 más

ReclutandoFase 1

Edades de 12 a 70 · Todos los sexos · Actualizado el 22 may 2026 · NCT06308978

A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell ( CAR-T) Therapy in Subjects With Non-relapsing and Progressive Forms of Multiple Sclerosis

Stanford Multiple Sclerosis Center, Palo Alto

ReclutandoFase 1

Edades de 18 a 65 · Todos los sexos · Actualizado el 27 feb 2026 · NCT06138132

Central Vein Sign in Multiple Sclerosis Extension Study

Cedars-Sinai Medical Center, Los Angeles

Reclutando

Edades de 18 a 65 · Todos los sexos · Actualizado el 20 feb 2026 · NCT07424027

Stelara and Tremfya Pregnancy Exposure Registry OTIS Autoimmune Diseases in Pregnancy Project

University of California, San Diego, La Jolla

ReclutandoEstudio observacional

Todas las edades · Mujeres · Actualizado el 28 ene 2025 · NCT02103361

Clinical Validation of the Role of microRNA Binding Site Mutations in Cancer Risk, Prevention and Treatment

MiraKind, Los Angeles

ReclutandoEstudio observacionalSe aceptan voluntarios sanos

Edades de 18 en adelante · Todos los sexos · Actualizado el 23 ene 2025 · NCT02253251

Mesenchymal Stem Cells for the Treatment of Various Chronic and Acute Conditions

Southern California Hospital at Culver City / Southern California Hospital at Hollywood / Multiple US-based Sub-Investigator Sites, Culver City

ReclutandoFase 1/2Se aceptan voluntarios sanos

Edades de 18 en adelante · Todos los sexos · Actualizado el 29 abr 2022 · NCT04684602

De ClinicalTrials.gov, datos obtenidos el 15 nov 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.